Gedi cube and renovaro biosciences sign definitive agreement to combine

Los angeles & amsterdam--(business wire)--gedi cube intl ltd. (gedi cube), an ai medical technology company, and renovaro biosciences inc. (nasdaq:renb) (renovaro), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy, have signed a definitive agreement to combine, in which gedi cube will become a wholly-owned subsidiary of renovaro in a stock-for-stock acquisition (the “transaction”). if completed, the transaction will result in a combined company that will offer advance.
RENB Ratings Summary
RENB Quant Ranking